Fact-checked by Grok 2 weeks ago

Micro-encapsulation

Microencapsulation is a versatile technology that involves enclosing active core materials—such as solids, liquids, or gases—within a protective or of to form microscopic capsules, typically ranging from 1 to 1000 micrometers in diameter. This process safeguards sensitive compounds from environmental stressors like oxygen, , , and changes, while enabling controlled release of the core at targeted sites or times. Widely applied across industries, microencapsulation enhances , , and functionality of encapsulated substances. The core material, often bioactive or functional (e.g., vitamins, , flavors, or pharmaceuticals), is surrounded by an encapsulant such as polymers (e.g., , alginate) or carbohydrates (e.g., ), forming structures like matrix, multi-walled, or reservoir types. Key properties include , , encapsulation (typically 70-99% depending on method), and mechanical strength, which influence release and . Common production methods encompass (economical and scalable for food applications), complex coacervation (high efficiency for oils), , coating, and emerging techniques like ionic gelation or processing. These approaches allow customization based on the core's and desired release profile, such as immediate, sustained, or stimuli-responsive (e.g., - or temperature-triggered). In the , microencapsulation fortifies products with nutrients like omega-3 fatty acids or antioxidants, masks off-flavors (e.g., in ), and supports viability in or baked goods, thereby extending and improving sensory attributes. Pharmaceutical applications leverage it for , reducing dosing frequency and side effects through controlled release microparticles. Other sectors include (fragrance encapsulation), ( delivery), and . Recent advances emphasize sustainability, with biodegradable shells from bio-based materials like () or achieving over 60% degradation in 28 days, aligning with environmental regulations such as the EU's microplastic bans. Challenges persist in , prevention, and energy-efficient manufacturing, but innovations like bioinspired inorganic shells (e.g., silica or ) promise reduced ecological impact without compromising performance. Overall, microencapsulation continues to evolve as a cornerstone of advanced material science and product innovation.

Fundamentals

Definition and Principles

Microencapsulation is a process by which micron-sized particles, droplets, or emulsions—collectively referred to as the core material—are enclosed within a continuous or to form microcapsules, typically ranging from 1 to 1000 μm in . This encapsulation creates a protective barrier that isolates the core from its surrounding environment, enabling functionalities such as controlled release and enhanced stability. The resulting microcapsules can be spherical or irregular in shape, with the shell material often forming a semi-permeable that regulates the of substances in and out. The underlying principles of microencapsulation revolve around the physical and chemical separation of phases to achieve encapsulation. Core isolation protects sensitive actives from external factors like oxygen, , , or changes, preventing degradation and extending . Controlled release is facilitated through mechanisms such as across the shell, , or rupture, allowing the core to be delivered at predetermined rates or in response to stimuli. Additional principles include , where immiscible phases are induced to form the shell around the core, and the use of semi-permeable barriers to mask undesirable sensory attributes like or while maintaining core integrity. These principles are achieved via methods like coacervation or , emphasizing the versatility of the technology in tailoring microcapsule performance. Microcapsules are classified into three primary types based on their internal structure: mononuclear, polynuclear, and . Mononuclear microcapsules consist of a single core surrounded by a shell, providing a for the active material. Polynuclear variants feature multiple cores aggregated within a single outer shell, allowing for higher loading capacity in a compact form. In contrast, matrix-type microcapsules involve the core material dispersed homogeneously throughout a continuous shell , without a distinct , which can enhance uniformity but may alter release kinetics. Key benefits of microencapsulation include enhanced of the core against environmental stressors, enabling targeted and improved without immediate exposure. This technology also supports precise control over release profiles, from immediate to sustained patterns, and effectively masks sensory properties to improve . Regarding size classification, microencapsulation specifically targets particles in the 1–1000 μm range, distinguishing it from nanoencapsulation, which operates at sub-micron scales below 1 μm for finer applications.

Historical Development

Microencapsulation technology originated in the early at the National Cash Register (NCR) Corporation, where chemists Barrett K. Green and Lowell Schleicher developed a method to enclose ink dyes in microscopic shells for use in pressure-sensitive . This innovation addressed the need for mess-free duplication, replacing traditional by relying on mechanical rupture of the capsules to release the core material. Their work built on earlier experiments, marking the first practical application of the . The process was patented in 1957 as US Patent 2,800,457, describing oil-containing microscopic capsules formed via coacervation. Commercialization followed swiftly, with NCR launching the first product on March 26, 1954, initially under the brand NCR Paper. By the 1960s, the technology expanded beyond paper into adhesives and textiles, where microcapsules enabled controlled release for enhanced performance, such as in pressure-sensitive adhesives and fabric treatments. Influential early adopters included military applications at , which explored multipurpose capsular adhesives. The 1960s saw initial adoption in pharmaceuticals, with sustained-release aspirin microcapsules developed for managing conditions like (e.g., via Wurster coating). In the late 1970s, researchers like Robert Langer at advanced polymer-based controlled systems, including microencapsulation techniques. In the , the embraced the method for flavor encapsulation, protecting volatile compounds and enabling controlled release in products. The 1990s brought biotech advancements, including probiotic microencapsulation to improve viability during processing and gastrointestinal delivery. Post-2000 developments emphasized for precise control and green synthesis methods using renewable resources to reduce environmental impact. This evolution shifted emphasis from initial mechanical coacervation to chemical methods like interfacial polymerization for greater precision, supported by thousands of patents filed globally by 2020.

Materials

Core Materials

Core materials in microencapsulation refer to the active substances enclosed within the protective shell, serving as the functional that imparts the desired properties to the final microcapsule product. These materials can exist in various physical states, including solids such as drugs, enzymes, and pigments; liquids like oils, flavors, and pheromones; gases such as oxygen used in applications; or even dispersions of multiple phases. The choice of core material is pivotal, as it determines the overall and application of the microcapsule, with the core typically comprising 5-90% by weight of the total formulation depending on the intended use. The properties of core materials significantly influence their suitability for encapsulation. plays a key role, with hydrophilic cores like certain enzymes requiring aqueous-compatible shells, while lipophilic ones such as essential oils demand oil-soluble coatings to ensure . and chemical is another critical factor; for instance, bioactives prone to degradation, like vitamins or , benefit from encapsulation to shield them from environmental stressors. Volatility affects handling and release, particularly for flavors or pheromones that evaporate readily, and bioactivity must be preserved to maintain therapeutic or functional efficacy, as seen in oxygen-loaded particles for where gas retention is essential. Essential oils, for example, are often selected despite their oxidation susceptibility because encapsulation mitigates during storage. Common examples span multiple industries. In pharmaceuticals, active ingredients like ibuprofen are frequently used as solid cores to enable controlled release and mask bitterness, with studies demonstrating high encapsulation efficiency in matrices. Food applications often involve or vitamins as core materials to enhance shelf-life and targeted delivery in the gut, protecting them from gastric acids. In agrochemicals, pesticides such as insecticides or pheromones serve as liquid or solid cores to reduce environmental exposure and enable sustained . Selection of core materials hinges on several factors to optimize performance. Compatibility with the shell is essential to prevent or instability, while the desired release rate—whether immediate or prolonged—influences and choices. Environmental addresses challenges like or , and preventing leakage requires low-porosity designs to avoid premature . These criteria ensure the core's integrity throughout processing and application. Preparation of core materials typically precedes full encapsulation, involving techniques like emulsification to disperse liquids or solids into fine droplets within a continuous , or to form solid particles from . These steps create a uniform core that can be readily coated, with emulsification being particularly suited for volatile liquids to minimize loss during handling.

Shell Materials

Shell materials, also known as wall or coating materials, form the outer layer of microcapsules, providing a protective barrier around the core while controlling the interaction with the external environment. These materials are selected to ensure stability, controlled release, and compatibility with the intended application, often influencing diffusion rates in release mechanisms. Shell materials are broadly classified into natural, synthetic, and hybrid types. Natural shell materials include proteins such as gelatin, polysaccharides like alginate and maltodextrin, and lipids such as waxes. Gelatin offers excellent film-forming properties and biocompatibility, making it suitable for encapsulating sensitive cores like oils. Alginate provides gelling capabilities and low toxicity, often used in pH-responsive systems. Synthetic shell materials encompass polymers like polyurea, polyurethane, and ethyl cellulose. Polyurea exhibits high chemical stability, acid and alkali resistance, and solvent resistance, enhancing thermal stability of the encapsulated material. Polyurethane provides tunable mechanical properties and a variety of chemical functionalities, allowing for adjustable permeability. Ethyl cellulose is valued for its transparent, flexible films with high strength and controlled drug release behavior. Hybrid materials, such as protein-polysaccharide complexes (e.g., gelatin-alginate), combine the benefits of natural components for improved elasticity and antimicrobial activity. Key properties of shell materials include mechanical strength, permeability, , and biodegradability. Mechanical strength varies; for instance, cross-linked alginate forms elastic gels, while shells offer robust structural integrity under . Permeability is governed by and can be tuned for diffusion-controlled release, with factors like (e.g., around 56°C for starch-based shells) affecting response to changes. is prominent in natural polymers like and , which are non-toxic and suitable for biomedical uses. Many natural shells, such as and alginate, are biodegradable, promoting environmental over synthetic options like polyacrylates. Selection criteria for shell materials emphasize core compatibility, environmental responsiveness, and regulatory approval. Compatibility ensures inertness and stabilization of the core, while responsiveness to stimuli like (e.g., ) or guides material choice. Regulatory aspects, such as (GRAS) status, are critical for food applications, applying to materials like and . Common examples illustrate practical use: shells for pharmaceuticals due to , maltodextrin for food flavors owing to GRAS status and protection of volatiles, and polyacrylates for controlled-release drugs via tunable permeability. is frequently employed for its film-forming strength in encapsulating oils. Modifications enhance shell performance; cross-linking, as in , improves mechanical strength and barrier properties, while (e.g., on ) adds functionality like UV resistance. Shell thickness typically ranges from 0.2 to 20 μm, influencing overall capsule and release .

Manufacturing Techniques

Coacervation

Coacervation is a physicochemical microencapsulation technique that involves of a into a -rich and a -poor , enabling the to deposit around core material droplets dispersed in the . This process, first described by Bungenberg de Jong and Kruyt in the , relies on controlled changes in conditions to induce the separation, forming a shell that encapsulates sensitive cores such as oils or bioactive compounds. The coacervation process typically proceeds in five main steps under continuous to ensure uniform deposition. First, the core material is dispersed as droplets in a solution to form an . Second, a coacervating agent is added or conditions are adjusted—such as shift, addition, change, or non-solvent introduction—to trigger . Third, the resulting phase deposits onto the core droplets, forming a liquid shell. Fourth, the shell is hardened through cross-linking (e.g., using or ) or cooling to solidify the microcapsules. Finally, the microcapsules are recovered by or and dried if needed. Coacervation variants include simple and complex types, distinguished by the number of s involved. Simple coacervation uses a single (e.g., or ) and is induced by desolvation agents like salts (e.g., ) or non-solvents (e.g., ), leading to via reduced polymer solubility. coacervation, more commonly applied in microencapsulation, employs two or more oppositely charged s (e.g., positively charged and negatively charged ), where is driven by electrostatic attractions optimized by adjusting pH to near the or . Other induction methods include temperature reduction for -based systems or non-solvent addition for broader compatibility. The underlying phase separation equilibrium in coacervation is often modeled using Flory-Huggins theory, which quantifies the of mixing for solutions as \Delta G_M / RT = n_1 \ln \phi_1 + n_2 \ln \phi_2 + \chi n_1 \phi_2, where n_1 and n_2 are the moles of solvent and , \phi_1 and \phi_2 are their volume fractions, R is the , T is , and \chi is the Flory-Huggins interaction parameter reflecting -solvent affinity; for complex coacervation, electrostatic contributions are added to favor the coacervate phase. This theoretical framework, extended by Voorn and Overbeek in the 1950s, predicts coacervation when \chi > 0.5, indicating immiscibility. Advantages of coacervation include mild operating conditions (typically at ambient temperature and neutral ), making it ideal for heat-sensitive cores like essential oils, and achieving high encapsulation efficiencies up to 99% with controlled shell thickness. Resulting microcapsules generally range from 10 to 500 μm in diameter, suitable for applications requiring visible but non-gritty particles. Limitations encompass its batch-wise nature, which hinders ; potential aggregation during deposition; and reliance on cross-linking agents that may introduce toxicity concerns, such as residual . A representative example is the encapsulation of flavor oils, such as orange essential oil, using complex coacervation with and as shell materials; the process protects volatile compounds from oxidation while enabling triggered release in matrices.

Spray Drying

Spray drying is a physical microencapsulation that involves atomizing a feed containing core and shell materials into a hot air stream, where rapid of the forms dry, encapsulated particles. This method is particularly suited for producing microcapsules with heat-stable cores dispersed in soluble wall materials, such as carbohydrates or proteins, to create a protective matrix around sensitive actives. The process begins with the preparation of a homogeneous feed by dispersing the core material in a of the shell material, often followed by homogenization to ensure . This is then pumped to an atomizer, where it is broken into fine droplets (typically 10-100 μm in size) via high-pressure nozzles or centrifugal forces. The droplets enter a co-current hot air stream at inlet temperatures of 100-250°C, leading to instantaneous as water evaporates, forming solid microcapsules that are subsequently separated and collected using a cyclone separator. Key parameters include feed (e.g., 0.4-144 mL/min), which influences droplet size and efficiency, and air , which affects in the chamber. Spray dryers typically consist of a feed reservoir, peristaltic pump, atomizer (nozzle types including pressure, two-fluid pneumatic, or centrifugal/rotary), drying chamber, heater for air (co-current or counter-current flow), cyclone for powder collection, and an exhaust system. Pressure nozzles generate droplets under high feed pressure (up to 100 bar), while two-fluid nozzles use compressed air for finer atomization suitable for viscous feeds, and centrifugal atomizers spin the feed to produce uniform particles at high throughput. These components enable scalable production, with advantages including cost-effectiveness (30-50 times cheaper than freeze drying), one-step operation, and high encapsulation efficiency for solid powders, making it ideal for industrial applications. However, limitations arise from thermal exposure, which can degrade heat-sensitive cores like oils or probiotics if inlet temperatures exceed optimal levels, and the requirement for water-soluble shell materials to facilitate drying. Wall material solubility ensures proper film formation, but sticky or low-solids feeds may cause nozzle clogging. Process optimization is often achieved through (RSM), which models interactions between variables like inlet temperature, feed rate, and solids content to maximize yield and minimize defects such as particle cracking. For instance, RSM has been used to balance drying kinetics and encapsulation efficiency in various systems. A representative example is the encapsulation of , such as Lactobacillus casei, using whey protein isolate as the shell material, where at 170°C inlet temperature achieved 97% cell survival, demonstrating the technique's utility for bioactive protection.

Interfacial Polymerization

Interfacial is a chemical microencapsulation technique that involves the formation of a shell at the between two immiscible phases, each containing complementary reactive . In this , one is typically dissolved in an aqueous phase while the other is in an organic phase, leading to specifically at the droplet upon mixing, which encapsulates the material dispersed within one of the phases. This process enables the creation of robust, thin-walled microcapsules suitable for protecting sensitive cores from environmental factors. The process begins with the emulsification of the core material, often hydrophobic, in a continuous aqueous to form droplets stabilized by emulsifiers. Next, monomers are added: for instance, an amine such as in the aqueous phase and an acid chloride or in the organic phase. Rapid occurs at the oil-water interface, driven by the high local concentrations of reactants, forming an initial that grows as monomers diffuse through it. Finally, the shell hardens through continued reaction or curing, yielding discrete microcapsules, with control over and uniformity achieved by adjusting stirring speed during emulsification. Variants of interfacial polymerization include polycondensation, where monomers like diamines and diacid chlorides react to form polyamides such as nylon shells, and polyaddition, involving reactions between diisocyanates and diamines to produce polyureas. The reaction kinetics generally follow a second-order rate law, expressed as \text{rate} = k [\text{monomer}_1][\text{monomer}_2], reflecting the bimolecular step-growth mechanism without requiring catalysts or elevated temperatures. These variants allow for tailoring shell properties, such as permeability, by selecting monomer functionalities. This technique offers advantages including the production of ultra-thin shells (typically 0.1-1 μm thick), which provide efficient barrier properties while minimizing material use, a rapid reaction time often completed in minutes, and versatility for encapsulating hydrophobic cores like oils or pesticides in aqueous systems. However, limitations include the potential toxicity of such as isocyanates, which require careful handling and removal to ensure product safety, and risks of incomplete reactions leading to porous or uneven shells, mitigated by optimizing stirring speed and ratios. A representative example is the encapsulation of pesticides using shells formed via interfacial of isocyanates and amines, enabling controlled release and reduced environmental ; for instance, xylene-based formulations have achieved high loading capacities up to 480 g/L with slower release profiles when using higher-functionality amines.

Emulsion Solvent Evaporation

The technique is a physicochemical for microencapsulation that involves dissolving a and the core material in a volatile , emulsifying the resulting in an aqueous , and then removing the through to precipitate the as a solid shell around the core. This approach is particularly effective for producing microspheres or microcapsules with uniform structures, leveraging induced by removal. The process consists of several key steps. First, the is dissolved in a volatile such as (), and the core material—often a hydrophobic —is dispersed or dissolved within this organic . Second, this organic is emulsified into a continuous aqueous containing a , such as (), to form droplets that prevent aggregation. Third, the is evaporated under continuous stirring, mild heating, or conditions, causing the to precipitate and solidify around the core, forming the microcapsules. Finally, the resulting microcapsules are recovered through washing to remove residual and , followed by drying via filtration or . Variants of this technique are tailored to the of the core material. For hydrophobic cores, a single oil-in-water (O/W) is used, where the -core solution forms the dispersed oil phase in water. For hydrophilic cores, such as water-soluble drugs, a water-in-oil-in-water (W/O/W) double is employed: the core is first emulsified in the solution to create a primary water-in-oil , which is then re-emulsified in the aqueous phase before solvent evaporation. These double emulsions are commonly applied in pharmaceutical formulations to encapsulate sensitive biologics. This method offers advantages for pharmaceutical applications, including the production of biodegradable polymer-based microcapsules with controlled particle sizes typically ranging from 1 to 100 μm, achieved through high-shear homogenization during emulsification. It enables high encapsulation efficiencies, often exceeding 90% for suitable polymer-core combinations, and supports for industrial production. However, limitations include the risk of residual organic in the final product, which requires rigorous purification to meet regulatory standards, and challenges in maintaining stability, which can lead to polydisperse particle sizes if not optimized. The rate of is governed by principles, as described by Fick's : the flux J = -D \frac{\partial C}{\partial x}, where D is the coefficient of the through the , and \frac{\partial C}{\partial x} represents the concentration gradient driving the from the droplets to the external phase. Incomplete can result in porous or collapsed structures, affecting . A representative example is the encapsulation of vitamin D3 in poly(lactic-co-glycolic acid) (PLGA) microspheres using the O/W single variant, yielding particles with mean diameters around 200-300 nm and encapsulation efficiencies up to 85%, demonstrating its utility for improving the and of lipophilic nutrients.

Characterization

Particle Size and

Particle size and morphology are fundamental physical properties of microcapsules that significantly influence their performance in various applications. The typical size range for microcapsules is 1 to 1000 μm, which determines aspects such as flowability, , and controlled release rates of the encapsulated material. Smaller particles generally enhance surface area and rates, while larger ones improve and handling. Morphology, including shape and surface characteristics, affects particle interactions, dispersion, and in suspensions. Several techniques are employed to characterize and . Optical provides initial visualization of particle and basic size estimation, while scanning electron microscopy (SEM) offers high-resolution images revealing detailed surface , such as spherical or irregular forms. (TEM) is used for internal structure analysis, particularly for thinner shells. For size distribution, diffraction is a standard method that measures the median diameter (D50) and polydispersity by analyzing light scattering patterns from particle ensembles. Advanced analysis involves image processing software to quantify parameters like , circularity, and from images, enabling precise morphological classification. measurement assesses electrostatic stability by evaluating surface charge, where values exceeding ±30 mV typically indicate good colloidal dispersion and resistance to aggregation. Factors such as the manufacturing technique and process parameters directly impact these properties; for instance, often produces uniform spherical particles, whereas coacervation may yield more irregular shapes. Stirring speed during emulsification inversely affects , with higher speeds (e.g., 1000–1300 rpm) reducing by increasing forces on droplets. Uniform size distribution correlates with higher encapsulation efficiency in subsequent assessments. Standardization is guided by international norms, including ISO 13320 for laser methods, which ensures reproducible measurements across 0.1–3000 μm for suspensions and powders relevant to microencapsulation. ISO 13322-2 specifies dynamic image analysis for and , incorporating morphological descriptors to evaluate non-spherical particles like microcapsules.

Encapsulation and Loading Capacity

Encapsulation efficiency (EE) quantifies the percentage of core material successfully enclosed within the microcapsule shell relative to the initial amount of core introduced during the process. It is calculated as
EE = \frac{\text{core encapsulated}}{\text{core initial}} \times 100\%
or, more commonly in practice,
EE = \frac{\text{total core} - \text{free core}}{\text{total core}} \times 100\% ,
where free core represents the unencapsulated portion separated from the microcapsules. Loading capacity (LC) measures the amount of core material incorporated relative to the total mass of the resulting microcapsules, expressed as
LC = \frac{\text{core encapsulated}}{\text{total capsule mass}} \times 100\% .
This metric highlights the payload density and is crucial for determining the practical utility of microcapsules in applications requiring high active content.
To measure EE and LC, the core material is typically extracted and quantified after separating free core via , , or . is widely used for cores with UV-visible , such as proteins or dyes, by dissolving the microcapsules in a suitable and measuring at a specific . (HPLC) provides higher specificity for complex cores, involving extraction of the encapsulated material followed by chromatographic separation and detection, often achieving detection limits in the range. For confirmation, assays like quantify leachable core by immersing microcapsules in a that disrupts the , measuring the initial rapid release of unencapsulated or surface-bound core via UV or HPLC. (DSC) serves as a , where successful encapsulation is confirmed by the absence or shift of the core's characteristic endothermic peak in the microcapsule thermogram, indicating molecular dispersion within the . Key factors influencing and include shell permeability, which determines core retention during formation and post-processing, and overall process , reflecting losses from aggregation or incomplete coating. Highly permeable shells, often due to thin or porous walls, can lead to core leakage, reducing , while optimized process parameters enhance by minimizing waste. In optimized methods like or coacervation, typical values range from 70% to 95%, demonstrating effective enclosure for scalable production. Optimization of EE and LC often involves adjusting emulsifier concentration in emulsion-based techniques, as higher levels stabilize the core-shell interface, reducing leakage and improving retention; for instance, increasing emulsifier from 1% to 5% w/v can boost EE by 20-30% in oil-in-water systems.

Release Mechanisms

Diffusion-Controlled Release

Diffusion-controlled release in microencapsulation occurs when the active core material migrates through the polymeric shell primarily via Fickian diffusion, a process governed by a across the shell without significant degradation. In this mechanism, solute transport follows Fick's laws, where the diffusion rate is slower than the polymer chain relaxation rate, leading to a predictable and steady release profile. This approach is particularly suited for sustained release applications, as it allows for prolonged delivery of the encapsulated substance over time. A key mathematical model describing this release is the Higuchi equation, originally derived for drug release from ointment bases but widely applied to microencapsulated systems with insoluble matrices. The equation is: Q = \sqrt{D (2C_0 - C_s) C_s \, t} where Q represents the amount of released substance per unit area, D is the of the core through the shell, C_0 is the initial concentration of the core in the shell, C_s is the of the core in the shell, and t is time. This model predicts a square-root time dependence for cumulative release, indicating that the amount released increases proportionally with the of time under pseudo-steady-state conditions, assuming no shell erosion or perfect sink conditions. Several factors influence the rate of diffusion-controlled release. Shell porosity facilitates easier passage of core molecules, thereby accelerating release, while increased shell thickness extends the diffusion path and slows it down. solubility directly impacts the concentration gradient driving , with higher promoting faster release. Additionally, chain mobility in the plays a critical role; when the exceeds the (T_g) of the , the material shifts to a rubbery state, enhancing chain flexibility and increasing the . This mechanism finds application in encapsulating flavors for food products, where diffusion enables gradual release to maintain taste over extended or during . In pharmaceuticals, it supports sustained of drugs such as from ethylcellulose microcapsules, providing controlled plasma levels while minimizing dosing frequency. To evaluate diffusion-controlled release, dissolution testing is commonly performed under sink conditions, where the receptor medium maintains a negligible bulk concentration relative to the core's (typically <10-20% ) to sustain the concentration gradient and mimic physiological environments.

Dissolution and Erosion-Controlled Release

In dissolution-controlled release, the microcapsule shell dissolves directly in the surrounding medium, leading to rapid disintegration and payload liberation once solubility thresholds are met, such as in aqueous environments where the shell material exhibits high solubility. This mechanism contrasts with passive diffusion by relying on the chemical solubility of the shell rather than transport through an intact barrier. Erosion-controlled release involves the of the polymeric shell, primarily through , which can proceed via surface —where chain scission and mass loss occur predominantly at the outer layer—or bulk , where penetrates uniformly into the matrix. Surface is typical of hydrophobic polymers like polyanhydrides, enabling predictable thinning of the shell, while bulk characterizes more hydrophilic polyesters such as (), where water ingress leads to internal bond cleavage before significant mass loss. These processes are often enzyme-catalyzed in biological settings, accelerating breakdown in targeted environments. Release from these systems are commonly described by zero-order models for constant-rate delivery in surface-eroding configurations, expressed as: Q = k t where Q is the amount released, k is the release constant, and t is time, ideal for maintaining steady therapeutic levels. apply to dissolution-dominant scenarios, following: \frac{dQ}{dt} = -k Q indicating an exponential decline proportional to remaining . For combined swelling and erosion, the semi-empirical Peppas models fractional release as: \frac{M_t}{M_\infty} = k t^n where M_t/M_\infty is the fractional release at time t, k incorporates structural and geometric factors, and the exponent n (typically 0.8–1.0 for erosion-controlled systems) distinguishes mechanisms from pure diffusion (n = 0.5). Influencing factors include pH, which triggers dissolution in responsive shells like enteric coatings designed to remain intact in acidic gastric fluid (pH ~2) but dissolve at intestinal pH (~6–7); temperature, elevating hydrolysis rates; and enzymatic activity, which cleaves polymer bonds in vivo. PLA exemplifies a bulk-eroding polymer sensitive to these variables, with degradation accelerating under neutral pH and physiological temperatures (~37°C). Advantages of these mechanisms encompass triggered, site-specific release—such as enteric coatings safeguarding acid-labile drugs for intestinal delivery—and zero-order profiles enabling sustained, uniform dosing without concentration peaks or troughs. profiling employs dissolution apparatus (e.g., paddle or basket types under Apparatus 1 or 2), simulating gastrointestinal conditions to quantify release rates and ensure reproducibility.

Applications

Pharmaceutical and Biomedical Applications

Microencapsulation plays a pivotal role in pharmaceutical drug delivery by enabling controlled and targeted release of active pharmaceutical ingredients (APIs), thereby enhancing therapeutic efficacy and patient compliance. In sustained release systems, microcapsules protect APIs from premature degradation and provide prolonged delivery, reducing dosing frequency. Site-specific delivery is achieved through enteric coatings that shield drugs from gastric acidity, allowing release in the intestines, as seen with polymers like Eudragit for gastrointestinal protection. Key advantages include improved by overcoming enzymatic degradation and poor , and minimized side effects through precise dosing and reduced systemic exposure. For example, microencapsulated antibiotics such as rifampin in microspheres have shown enhanced efficacy against infections with minimal dosing regimens, improving treatment outcomes in therapy. The pharmaceutical microencapsulation market, driven by these applications, is projected to expand significantly, with the global market valued at USD 15.38 billion in 2024 and expected to reach USD 24.07 billion by 2029. In biomedical contexts, microencapsulation facilitates cell-based therapies by immunoisolating transplanted cells, preventing host rejection without . Alginate-polylysine microcapsules encapsulating have sustained normoglycemia in diabetic patients for months, with one clinical case showing viable porcine islets after 9.5 years and a 30% reduction in insulin needs. For , encapsulated cells secreting anti-tumor factors like endostatin have inhibited tumor growth by providing sustained local delivery. immobilization within microcapsules enhances biosensor stability and activity; for instance, microencapsulated urease-producing bacteria reduced plasma urea by 18% in uremic rat models over 8 weeks. Vaccine delivery benefits from microencapsulation for , bypassing injections and improving mucosal immunity. Microencapsulated antigens in alginate microspheres elicited protective responses in animal models, demonstrating stability across variations and enhanced immune stimulation. Regulatory approval supports these applications, with FDA-cleared polymers like Eudragit enabling safe enteric and sustained release formulations in commercial products. Overall, these advancements underscore microencapsulation's potential to transform and .

Food and Nutraceutical Applications

Microencapsulation plays a pivotal role in the food and industries by protecting sensitive bioactive compounds, enhancing their , and enabling controlled within edible matrices. In food applications, it safeguards flavors, vitamins, and from degradation during processing, storage, and , while in nutraceuticals, it improves and masks off-flavors to promote consumer acceptance. This technology utilizes food-grade wall materials such as , , and alginate to encapsulate core materials like oils and cells, primarily through methods like and coacervation. One primary application is in and aroma encapsulation, where microencapsulation masks bitterness and controls release to maintain sensory appeal. For instance, has been used to encapsulate mint flavors in , providing sustained release over extended periods, while beta-cyclodextrin encapsulates essential oils like to preserve aroma in meat products without altering taste. In beverages, spray-dried microcapsules of fruit flavors, such as oils, prevent volatilization and stabilize volatile compounds against oxidation and . These approaches also reduce in products like baked goods. In nutraceuticals, microencapsulation protects and vitamins from environmental stressors, ensuring viability and efficacy in functional foods and supplements. Probiotic , such as and L. plantarum, are encapsulated in alginate or matrices via , achieving viabilities exceeding 8 log CFU/g after 180 days of storage at 25°C in , compared to rapid declines in free cells. For vitamins, omega-3 fatty acids from are microencapsulated with and gum , retaining stability at 43°C in milk powders and reducing oxidation in fortified breads. Similarly, and are protected in emulsions, enhancing in simulated models. Functional foods benefit from encapsulated antioxidants and enzymes, which maintain and process compatibility. Anthocyanins from , microencapsulated with , retain activity in baked products like , providing protection against . Enzymes such as , encapsulated via coacervation, remain active in , aiding lactose-intolerant consumers without impacting . The benefits of these applications include extended —such as for minced fortified with microcapsules at 4°C—and improved sensory profiles, like reduced fishy odors in omega-3-enriched nuggets. Market growth underscores this impact, with the global encapsulation sector valued at approximately USD 7.1 billion in 2025 and projected to reach USD 18.0 billion by 2035 at a 9.8% CAGR, driven by for fortified products. Challenges persist in ensuring food-grade material compatibility and processing scalability, as high temperatures in can reduce encapsulation efficiency to below 80% for heat-sensitive , necessitating innovations like . Regulatory approval for materials like modified starches remains essential to avoid into matrices, while cost barriers limit widespread adoption in low-margin products.

Agricultural and Environmental Applications

Microencapsulation plays a pivotal role in agricultural applications by enabling controlled release of agrochemicals, such as and fertilizers, to enhance while minimizing environmental harm. In delivery, microencapsulated formulations, particularly those using coatings, protect active ingredients like herbicides from premature degradation and reduce into and bodies. For instance, microcapsules containing oxyfluorfen provide sustained release, improving duration and lowering the required application rates by up to 30-50% compared to conventional sprays. This targeted approach decreases non-point source , as demonstrated with ethylcellulose-encapsulated and , which exhibit significantly lower mobility in and reduced contamination risks. Fertilizer encapsulation similarly promotes sustainable , with often coated in polymers like or alginate to achieve slow release aligned with needs. -based microcapsules for NPK compounds, for example, prevent rapid dissolution, reducing by controlling and mechanisms for timed availability. These formulations enhance use efficiency, supporting higher yields; in fields, microencapsulated and mixtures maintained effective (against white grubs) throughout the season with a single , stabilizing concentrations 2-14 times higher than non-encapsulated versions and minimizing repeated applications. Case studies in vineyards further illustrate benefits, where microencapsulated fungicides achieved equivalent control to conventional products but with 50% less , curbing accumulation and supporting . In cultivation, polylactic acid-encapsulated herbicides boosted yields by improving weed suppression without long-term residue effects on subsequent crops. European Union regulations under the Fertilising Products Regulation encourage encapsulated agrochemicals by exempting coatings from microplastic restrictions, provided they degrade fully by 2026, thereby favoring sustainable options that align with zero-pollution goals. In environmental remediation, microencapsulation facilitates the deployment of enzymes for pollutant degradation, such as laccases and lipases enclosed in shells for cleanup, which shield the enzymes from UV exposure and enable controlled release to break down s into non-toxic byproducts like CO₂ and . This method accelerates recovery, with field applications reducing levels by 85% within six weeks post-spill. For , microcapsule shells, such as those derived from sulfonated nanocrystals, degrade enzymatically within 14 days after release, minimizing residual accumulation in and systems while prolonging efficacy and reducing non-target .

Challenges and Future Directions

Current Limitations

Microencapsulation processes often suffer from technical limitations, such as low yields in certain methods like complex coacervation, where encapsulation efficiency can vary due to factors including aggregation and sensitivity to , , and variations. Shell defects, including and inconsistencies in thickness (e.g., 40-60 variations in shells), frequently lead to unintended burst release of core materials, compromising controlled delivery. is another challenge, as variability in , distribution, and shell uniformity across batches hinders consistent outcomes, particularly in layer-by-layer and emulsion-based techniques. Economically, scaling up microencapsulation remains costly, with equipment for spray drying operations typically exceeding $100,000 for medium-scale systems (e.g., $50,000-$200,000 range), and additional expenses arising from high energy demands (e.g., 360 MJ/m³ in high-pressure homogenization) and solvent recovery processes. These factors limit industrial adoption, especially for methods requiring bespoke materials or templates, such as lithography-based approaches. Regulatory hurdles include toxicity concerns with synthetic polymers and cross-linkers (e.g., residual levels up to 235 in melamine-formaldehyde shells), prompting stringent FDA and scrutiny on residuals and for food and pharmaceutical applications, which can delay approvals. As of 2025, the 's restriction on intentional addition of in products ( (EU) 2023/2055, implemented progressively) further impacts the use of non-biodegradable polymers like and polyurethanes. Additionally, non-biodegradable from such polymers contributes to environmental impacts, including pollution estimated at over 42,000 tonnes annually in the . In probiotic applications, post-encapsulation viability poses a specific challenge, with survival rates dropping below 50% in some cases (e.g., 16-47% after simulated in freeze-dried samples), affecting in and biomedical uses. Recent advancements in micro-encapsulation have focused on the development of smart microcapsules that respond to external stimuli for controlled release, enhancing precision in applications such as . Stimuli-responsive systems, including those triggered by magnetic fields or light, have been engineered using composites to enable on-demand payload release, addressing challenges like scale-up in biomedical targeting. For instance, pH- and ROS-sensitive microcapsules integrated with allow for targeted activation in tumor environments, improving therapeutic while minimizing off-target effects. Nanohybrid approaches are integrating micro-encapsulation with nanoparticles to achieve multi-functionality, particularly in co-delivery systems for drugs and genes. These structures combine nanoparticles with polymeric shells to protect nucleic acids during transport, enabling simultaneous delivery that overcomes physiological barriers like endosomal escape. Recent innovations include nanostructured carriers (NLCs) and solid nanoparticles (SLNs) encapsulated within microcapsules for sustained , demonstrating improved and reduced in preclinical models. Green methods for micro-encapsulation emphasize solvent-free techniques and bio-based shells to promote , with algal emerging as versatile wall materials due to their and renewability. These , such as alginate derived from , form protective matrices through ionic gelation without solvents, reducing environmental impact while maintaining high encapsulation efficiency. Additionally, technologies are enabling the fabrication of custom microcapsules using natural like and , allowing precise control over size and shape for tailored release profiles. Market trends indicate robust growth in micro-encapsulation, driven by demands in and , with the global market projected to reach $23.131 billion by 2030 at a CAGR of 6.83%. In , advancements in stimuli-responsive systems are facilitating patient-specific drug formulations, while in , micro-encapsulated pesticides are expected to grow to $850 million by 2030, supporting eco-friendly through controlled release that minimizes environmental residue. Research frontiers are exploring AI-optimized designs for micro-encapsulation, leveraging to predict optimal shell compositions and release , thereby accelerating in self-healing capsules. These AI-driven approaches simulate polymer interactions to capsules that autonomously repair cracks in materials, enhancing in coatings and composites. Self-healing microcapsules, often incorporating core-shell structures with healing agents like polyurea-formaldehyde, are advancing toward that respond to damage in real-time, with potential extensions to biomedical self-repairing implants.

References

  1. [1]
    Microencapsulation: An overview on concepts, methods, properties ...
    Jun 18, 2021 · Microencapsulation is an advanced food processing technology, using which any compound can be encapsulated inside a particular material, ...
  2. [2]
    Microencapsulation as a Noble Technique for the Application ... - MDPI
    This review provides an in-depth discussion on recent advances in microencapsulation processes as well as their application in food systems.Microencapsulation As A... · 3. Microstructure Of... · 4.2. Coacervation TechniqueMissing: definition | Show results with:definition<|control11|><|separator|>
  3. [3]
    Current Challenges in Microcapsule Designs and ...
    Jul 23, 2024 · This review provides an overview of advances in microencapsulation, with emphasis on sustainable microcapsule designs.
  4. [4]
    Microencapsulation: A promising technique for controlled drug delivery
    This article gives an overview on the general aspects and recent advances in drug-loaded microparticles to improve the efficiency of various medical treatments.
  5. [5]
    Microencapsulation - an overview | ScienceDirect Topics
    Microencapsulation is defined as a process where a liquid or suspension is enclosed in a semipermeable membrane, which may be polymeric, lipoidal, lipoprotein- ...
  6. [6]
    Microencapsulation | Invention & Technology Magazine
    Reading the last copy in a stack was often a challenge. By 1942 Green, working with Lowell Schleicher, had developed a working method of microencapsulating ink ...
  7. [7]
    Oil-containing microscopic capsules and method of making them
    GREEN LOWELL SCHLEICHER 6 THEIR ATTORNEYS 2,800,457 Patented July 23, 1957 ice OIL-CONTAINING MICROSCOPIC CAPSULE AND BETH- D OF MAKING THEM Barrett K.
  8. [8]
    Appvion marks 60 years of making carbonless paper - PR Newswire
    Mar 24, 2014 · The first commercial sale took place on March 26, 1954. NCR PAPER* brand carbonless paper has been exclusively manufactured by Appvion since ...Missing: date | Show results with:date
  9. [9]
    Microencapsulation – How it All Began - Gordon College
    Green went to work for the National Cash Register (NCR) Corporation. Green was especially interested in the chemistry of colloids - particles that don't ...
  10. [10]
    Microencapsulation: A Brief History and Introduction - SpringerLink
    The Use of Sustained Release Aspirin in Preparation and Management of Rheumatoid Arthritis, J. of Clincal Phar. (March–April, 1967). Google Scholar.
  11. [11]
    Microencapsulation with Robert Langer Sc.D
    Microencapsulating is the scientific process which creates a protective barrier around a cell and has been a lifesaving technology for a variety of conditions.
  12. [12]
    Probiotic Encapsulation Technology: From Microencapsulation to ...
    Feb 6, 2012 · Since its emergence in the 1990s ... Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery.Missing: biotech | Show results with:biotech
  13. [13]
    Green Synthesis of Nanomaterials - PMC - NIH
    Green synthesis is a method just as effective, if not more so, than traditional synthesis; it provides a sustainable approach to nanomaterial manufacturing.
  14. [14]
    Microencapsulation: An overview on concepts, methods, properties ...
    Jun 18, 2021 · In this method, the microcapsules are made to come in contact with an aqueous high molecular weight polymer with a continuous phase.
  15. [15]
    Recent applications of microencapsulation techniques for delivery of ...
    Microencapsulation depends on several factors, 1) properties of core material. 2) properties of encapsulant, 3) interaction between core material ...
  16. [16]
    Oxygen delivery using engineered microparticles - PNAS
    We describe a polymeric microparticle-based oxygen delivery technology capable of rapidly administering large volumes of oxygen gas through an intravenous line.<|control11|><|separator|>
  17. [17]
    Encapsulation of Ibuprofen by Pickering-Stabilized Antibubbles
    Ibuprofen was encapsulated in Pickering antibubbles using two different oils, cyclomethicone and cyclooctane, as processing aids.
  18. [18]
    Biopolymers-based microencapsulation technology for sustainable textiles development: A short review
    ### Summary of Biopolymer Shell Materials for Microencapsulation in Textiles
  19. [19]
    Microencapsulation of Photochromic Solution with Polyurea ... - MDPI
    Polyurea is a promising wall material in microcapsules due to its chemical stability, acid and alkali resistance, and solvent resistance. Usually, polyurea ...
  20. [20]
    New Polyurethane/Docosane Microcapsules as Phase‐Change ...
    Jun 26, 2015 · In this research, polyurethane (PU) was selected as a capsule shell material because of: 1) a great variety of chemical and mechanical ...
  21. [21]
    (PDF) Ethylcellulose microparticles: A review - ResearchGate
    Aug 5, 2025 · This review encompasses microencapsulation techniques, core substances and other fundamentals involved in the preparation and characterization of EC ...
  22. [22]
    Controlling the Synthesis of Polyurea Microcapsules and the ... - NIH
    Jan 18, 2024 · The microcapsules are composed of a PVOH-polyurea composite shell and a liquid core containing IPDI. Aiming at a more effective encapsulation ...
  23. [23]
    Preparation and characterization of ethyl cellulose-based core–shell ...
    Microcapsules with a regular spherical shape 10–50 μm in diameter and 0.65–1.55 μm in shell thickness were successfully synthesized using either ethyl acetate ...
  24. [24]
  25. [25]
  26. [26]
  27. [27]
    Advances in Spray-Drying Encapsulation of Food Bioactive ...
    Jan 16, 2019 · In this review, the spray-drying process is described, as are recent trends in the encapsulation of fish oils, essential fatty acids ...
  28. [28]
    [PDF] Spray Drying for the Encapsulation of Oils—A Review
    Aug 26, 2020 · Abstract: The application of the spray drying technique in the food industry for the production of a broad range of ingredients has become ...
  29. [29]
    Spray Drying for the Encapsulation of Oils—A Review - PMC - NIH
    The dried particles are spherical in shape with a size range from 10 to 100 micrometres [32].
  30. [30]
    None
    ### Summary on Spray Drying for Microencapsulation
  31. [31]
    Optimization of spray drying microencapsulation of olive pomace ...
    This study was performed to determine the optimum conditions for spray drying microencapsulation of olive pomace extract, in order to stabilize its phenolic ...
  32. [32]
    Determination of the Optimum Conditions for Emulsification and ...
    Jul 28, 2023 · The aim of this study was to obtain the optimum conditions of microencapsulation of EO using spray drying by applying the response surface methodology (RSM).
  33. [33]
    (PDF) Microencapsulation by interfacial polymerisation: Membrane ...
    The process consists in the dispersion of one phase containing a reactive monomer, into a second immiscible phase to which is added a second monomer.
  34. [34]
    A Multi-Scale Approach to Microencapsulation by Interfacial ... - NIH
    Feb 22, 2021 · Interfacial polymerization is a microencapsulation method widely used for the production of pesticides [7,8], phase change materials [9,10], ...Missing: limitations | Show results with:limitations
  35. [35]
    Kinetics of interfacial polycondensation reactions - ScienceDirect.com
    Oct 3, 2017 · Interfacial polycondensation (IP) is a step growth polymerization of two monomers dissolved in two immiscible phases. It is widely used in the ...
  36. [36]
  37. [37]
    Solvent Evaporation - an overview | ScienceDirect Topics
    After the formation of stable emulsion, the organic solvent is evaporated either by increasing the temperature under reduced pressure or by continuous stirring ...
  38. [38]
    (PDF) Microencapsulation by solvent evaporation: State of the art for ...
    Aug 10, 2025 · Microencapsulation by solvent evaporation technique is widely used in pharmaceutical industries. It facilitates a controlled release of a drug, which has many ...
  39. [39]
    PLGA Nanoparticles Formed by Single- or Double-emulsion ... - NIH
    Here, we describe a technique for making PLGA nanoparticles using single and double emulsion, with ethyl acetate (EtAc) as the solvent and vitamin E- D-α- ...
  40. [40]
    Design of Experiment for Optimizing Microencapsulation by ... - MDPI
    Dec 29, 2023 · With the solvent evaporation technique, the size and stability of the emulsion droplets are closely correlated with the size of the final MCs, ...
  41. [41]
    Microencapsulation: Solvent evaporation - ScienceDirect.com
    This technique is carried out by using emulsion-based systems including oil-in-water (o/w) emulsion and water-in-oil-in-water (w/o/w) double emulsions.
  42. [42]
    PLGA nanoparticles as a platform for vitamin D-based cancer therapy
    The single emulsion solvent evaporation method allowed the encapsulation of vitamin D3 in the PLGA NPs. The obtained results for the mean diameter, PDI, zeta ...Plga Nanoparticles As A... · Nanoparticle Physicochemical... · Calcitriol Release From The...
  43. [43]
    Comparison of Microencapsulation by Emulsion-Solvent Extraction ...
    An appropriate type and optimum concentration of polymer were used for microencapsulation of a drug by the emulsion solvent diffusion/evaporation technique (7).
  44. [44]
    Study of the organic solvent template double emulsions for porous ...
    Jul 20, 2018 · A theoretical approach was developed to investigate the influence of solvent type on water permeation across the solvent film in w/o/w template ...
  45. [45]
    Optimization of a Microencapsulation Process Using Oil-in-Water (O ...
    Oct 22, 2023 · The aim of this work was to optimize a microencapsulation process using oil-in-water emulsion to increase the thermal stability of SFN.
  46. [46]
    Relation between the particle size and release characteristics of ...
    Aug 13, 2019 · Microencapsulation, as a protective technique designed to seal active ingredients within micro-scale particles, is widely considered to be ...
  47. [47]
  48. [48]
    Suspension Stability: The importance of Zeta Potential, Particle Size ...
    Nov 30, 2010 · If all the particles in suspension have a large negative or positive zeta potential then they will tend to repel each other and there will be no ...
  49. [49]
    Stirring speed influence study on the microencapsulation process ...
    Obtained results show that the relationship found between the Sauter mean diameter of particles and the stirring speed of emulsification is in good agreement ...
  50. [50]
    Composition analysis and microencapsulation of Eucommia ... - NIH
    Aug 23, 2021 · Stirring speed. With increasing stirring speed, the particle size of the E. ulmoides seed oil microcapsules decreased (Fig. 5). At stirring ...
  51. [51]
    ISO 13320:2020 - Particle size analysis — Laser diffraction methods
    In stock 2–5 day deliveryThis document provides guidance on instrument qualification and size distribution measurement of particles in many two-phase systems.
  52. [52]
  53. [53]
    Drug Release Kinetics and Transport Mechanisms of Non ... - NIH
    Fickian diffusion refers to the solute transport process in which the polymer relaxation time (tr) is much greater than the characteristic solvent diffusion ...
  54. [54]
    Fickian Diffusion - an overview | ScienceDirect Topics
    Fickian diffusion refers to a solvent diffusion process in polymer networks characterized by a diffusion rate that is significantly slower than the polymer ...
  55. [55]
    Mechanism of sustained‐action medication. Theoretical analysis of ...
    Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. T. Higuchi ...Missing: original | Show results with:original
  56. [56]
    Review Higuchi equation: Derivation, applications, use and misuse
    The legendary Professor Takeru Higuchi published the derivation of an equation that allowed for the quantification of drug release from thin ointment films.Missing: microencapsulation paper
  57. [57]
    Porous microcapsules with tunable pore sizes provide easily ...
    Aug 7, 2025 · Furthermore, the porosity of the microcapsules determined their release properties and further regulated the bioactivity of the microcapsules.
  58. [58]
    Experimental validation and preliminary modeling of diffusion ...
    Jul 29, 2025 · Diffusion kinetics strongly depended on shell thickness and bitumen aging degree. Thinner-shelled microcapsules showed superior rejuvenation ...Missing: affecting | Show results with:affecting
  59. [59]
    Glass Transition Temperature of PLGA Particles and the Influence ...
    This review summarizes the basic knowledge of the glass transition temperature in PLGA particles, the factors that influence the T g , the effect of T g on ...
  60. [60]
    [PDF] MICROENCAPSULATION OF FOOD FLAVORS - JETIR.org
    May 1, 2020 · Diffusion is important in food because it is the dominant mechanism in controlled release from encapsulation matrices. It should be obvious that ...
  61. [61]
    Theophylline-Ethylcellulose Microparticles: Screening of the ... - NIH
    The release of theophylline was found to be diffusion controlled and was influenced by the drug to polymer ratio, loading efficiency, and particle size.Missing: applications flavors
  62. [62]
    Impact of sink conditions on drug release behavior of controlled ...
    The release behavior showed a strong dependence on sink conditions for drugs with low intrinsic solubility, while highly soluble drugs were unaffected by ...
  63. [63]
    Development And Validation Of In Vitro Release Testing For ...
    Sink conditions exist when a receptor medium has a relatively “high capacity to dissolve or carry away the drug” and the receptor media “exceed[s] 10% of Cs ( ...
  64. [64]
    Microencapsulation for the Therapeutic Delivery of Drugs, Live ...
    The controlled release of the drug through microspheres/microcapsules occurs via four known mechanisms, namely, diffusion, dissolution, osmosis, and erosion.
  65. [65]
    Why degradable polymers undergo surface erosion or bulk erosion
    The model shows that all degradable polymers can undergo surface erosion or bulk erosion. Which way a polymer matrix erodes after all depends on the diffusivity ...
  66. [66]
    Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications
    Factors such as polymer composition (glycolic/lactic acid ratio), pH, hydrophilicity in the backbone, water absorption, glass transition temperature (Tg), and ...
  67. [67]
    PLGA/PLA-Based Long-Acting Injectable Depot Microspheres ... - NIH
    Several factors, including temperature, pH, and presence of enzymes and surfactants, can expedite the rate of polymer hydration/degradation and drug diffusion, ...
  68. [68]
    Release behavior of different physicochemical properties drug ...
    The release profiles from all the microcapsules were best explained by Higuchi model based on highest linearity, followed by zero order and first order. It ...
  69. [69]
    A simple equation for description of solute release I. Fickian and non ...
    The equation M_t/M_∞ = kt^n describes solute release, where M_t/M_∞ is fractional release, t is time, k is a constant, and n is the diffusional exponent.
  70. [70]
    Enteric Coating - an overview | ScienceDirect Topics
    The main advantage of enteric coating is that it protects the drug from acidic pH and enzymatic degradation in the stomach while protecting it from the ...
  71. [71]
    Pharmaceutical Application of Tablet Film Coating - PMC - NIH
    Sep 8, 2020 · The main advantage of enteric coating is increasing drug stability in the harsh gastric environment and/or reducing undesirable gastric ...
  72. [72]
    Preparation and evaluation of verapamil hydrochloride microcapsules
    The size analysis of prepared microcapsules was done by a standard sieving method and in vitro dissolution studies were carried out in USP XXI dissolution test ...
  73. [73]
    A Systematic Overview of Eudragit® Based Copolymer for Smart ...
    Feb 9, 2023 · Eudragit, synthesized by radical polymerization, is used for enteric coating, precise temporal release, and targeting the entire gastrointestinal system.
  74. [74]
    Microencapsulation for Pharmaceutical Applications: A Review
    Feb 19, 2024 · Microencapsulation improves bioavailability, stability, control release, and target delivery of APIs, and masks bitter taste, increasing ...
  75. [75]
    Efficacy of Microencapsulated Rifampin inMycobacterium ...
    These results demonstrate that microsphere formulations of antimycobacterial drugs such as rifampin can be used for therapy of tuberculosis with minimal dosing.<|control11|><|separator|>
  76. [76]
    Microencapsulation Market Size, Share, and Forecast
    The global microencapsulation market is estimated at USD 15.38 billion in 2024, and is projected to reach USD 24.07 billion by 2029, at a CAGR of 9.4%Attractive Opportunities In... · The Asia Pacific Region Is... · Recent Developments Of...
  77. [77]
  78. [78]
    Protective antibody response following oral vaccination with ... - Nature
    Jul 10, 2020 · In this study, we report the development of a microencapsulated oral vaccine against anthrax. Evaluating Sterne spore stability at varying pH's in vitro ...
  79. [79]
    [PDF] GRAS Notice 710, Basic methacrylate copolymer - FDA
    Jun 2, 2017 · Basic Methacrylate Copolymer is manufactured by Evonik Röhm GmbH and sold under the trade name,. Eudragit®. It is currently approved as an ...
  80. [80]
  81. [81]
  82. [82]
  83. [83]
  84. [84]
  85. [85]
    Food Encapsulation Market Size & Forecast 2025 to 2035
    The global food encapsulation market is valued at USD 7.1 billion in 2025 and is projected to achieve USD 18.0 billion by 2035, at a CAGR of 9.8% from 2025 to ...
  86. [86]
    (PDF) Design and application of polyurea microcapsules containing ...
    Polyurea, a controlled release material, has been widely applied in agricultural fields due to high thermal stability and low cost.
  87. [87]
    An efficient carrier for enhanced herbicidal activity of pretilachlor and ...
    Jan 15, 2021 · In light of this, preparing polyurea herbicide microcapsules can realize purpose of weed control while minimizing toxic effects and reducing ...
  88. [88]
    Controlled release formulations of herbicides based on micro ...
    Microencapsulated in EC, they reduce mobility (Sopeña et al, 2007a; 2007b) and protect herbicides against degradation in the soil-water system (Sopeña et al, ...
  89. [89]
    Preparation of Microcapsules of Slow-Release NPK Compound ...
    In this study, a novel type of slow-release fertilizer (SRF) was synthesized through lignin-based microcapsules. K2HPO4 and urea were coated by lignin and ...<|separator|>
  90. [90]
    Controlled Release Study on Microencapsulated Mixture of Fipronil ...
    This study was conducted to determine the release dynamics of a microencapsulated mixture of fipronil and chlorpyrifos in peanut fields and its efficacy ...<|separator|>
  91. [91]
    Design and evaluation of microencapsulation technology to reduce ...
    Microencapsulated copper product has higher deposition than a conventional copper fungicide. The developed product can offer a potential 50% reduction of the ...
  92. [92]
    Encapsulation of Herbicides for Weed Control - MDPI
    This article offers a critical analysis of the evolution of encapsulation methods for herbicides and natural products, with a main focus on organic ...
  93. [93]
    Micro plastics - Fertilizers Europe
    The EU Fertilizing Products Regulation already sets the rules for controlled-released fertilizers. As such, polymer encapsulation systems for fertilizers ...Missing: agrochemicals | Show results with:agrochemicals
  94. [94]
    Major Oil Spill Enzyme Remediation - BioGlobe
    Enzymes are enclosed in marine-stable polymer microcapsules, which: Shield them from environmental stressors. Control their release over time. Target specific ...Missing: microencapsulation | Show results with:microencapsulation
  95. [95]
    Biodegradable Pesticide Microcapsules: Safety Enhancement
    Mar 1, 2024 · This study highlights the eco-friendly production of microcapsules and their capacity to diminish the negative impacts associated with pesticide application.
  96. [96]
  97. [97]
  98. [98]
    Current Challenges in Microcapsule Designs and ... - NIH
    This review provides an overview of advances in microencapsulation, with emphasis on sustainable microcapsule designs.
  99. [99]
    Spray Drying Equipment Price Guide | What You Need to Know ...
    May 21, 2025 · Suitable for medium-sized operations, prices typically range from $50,000 to $200,000. Medium-scale spray dryers are designed for businesses ...
  100. [100]
    [PDF] Microencapsulation in Food Industry - ijrpr
    Approval of Encapsulating Agents: Regulatory bodies, such as the FDA and EFSA, require thorough evaluations of encapsulating materials to ensure they are safe ...<|separator|>
  101. [101]
    Effect of Drying Process, Encapsulation, and Storage on the Survival ...
    In freeze dried samples, encapsulated microorganisms showed a survival rate of 16–47% at the end of digestion. The different characteristics of the food matrix ...
  102. [102]
    From mechanism to applications: Advanced microneedles for ...
    Meanwhile, stimuli-responsive systems (e.g., pH/ROS-triggered MNs) require advanced fabrication techniques like aerosol jet printing, escalating costs. For ...
  103. [103]
    Current approaches in smart nano‐inspired drug delivery - NIH
    Apr 24, 2024 · Current smart drug delivery approaches include nanoparticles, liposomes, micelles, and hydrogels, each with its own advantages and limitations.
  104. [104]
    Nanoarchitecting intelligently encapsulated designs for improved ...
    In this review, we present various smart approaches for cancer therapy, including organic materials, inorganic components, and their composites.
  105. [105]
    Nano Approaches to Nucleic Acid Delivery: Barriers, Solutions, and ...
    Apr 13, 2025 · This review article describes various physiological barriers to NA delivery and explores nanoparticle‐based NA delivery systems.
  106. [106]
    Advances in nanocarrier technology for drug encapsulation
    Jul 8, 2025 · This review discusses nanostructured lipid carriers (NLC), solid lipid nanoparticles (SLN), from physical encapsulation, and magnetic nanoparticles (MNP) from ...
  107. [107]
    Recent Advances in Micro- and Nano-Drug Delivery Systems Based ...
    This review discusses all the above components and how, by combining synthetic and biological approaches, micro- and nano-drug delivery systems can result in ...
  108. [108]
    Biomaterial in Microencapsulation - IntechOpen
    In this review, we discuss about new materials, their application for microencapsulation and how these materials can alter drug delivery and treatment of ...<|separator|>
  109. [109]
    3D Printing of Hydrogel Polysaccharides for Biomedical Applications
    Additive manufacturing, also known as 3D printing, is becoming more and more popular because of its wide range of materials and flexibility in design.
  110. [110]
    [PDF] Review Article Natural biopolymer for 3D printing - Semantic Scholar
    Jan 12, 2024 · Natural biopolymers like collagen, chitosan, alginate, gelatin, hyaluronic acid, and cellulose are used in 3D printing for applications such as ...
  111. [111]
    Microencapsulation Market Report: Share, Trends, Forecast 2030
    Microencapsulation Market forecast to hit $23.131 billion by 2030 from $6.626 billion in 2025, at 6.83% CAGR. Major players: Givaudan SA, Evonik Industries ...
  112. [112]
    Microencapsulated Pesticides Market Size, Share & 2030 Growth ...
    Aug 14, 2025 · The global microencapsulated pesticides market size stands at USD 520 million in 2025 and is on track to reach USD 850 million by 2030, ...Missing: personalized medicine
  113. [113]
    A review on self-healing featured soft robotics - Frontiers
    This article gives an in-depth overview of the existing knowledge base on damage resistance and self-healing materials' fundamental structure and ...
  114. [114]
    Active-enhanced core-shell microcapsules for self-healing ...
    May 9, 2025 · This study develops multi-healing core-shell microcapsules consisting of a core (polyurea formaldehyde sub-capsules containing sunflower oil) and a shell ( ...Missing: frontiers | Show results with:frontiers